Insights On Outsourced Drug Development
-
Overcoming Method Transfer Challenges
6/24/2022
Although development and quality control labs might be slow to replace existing technologies, modernization can benefit legacy methods and future development activities.
-
Getting Genomic Medicines Ready For Prime Time
2/5/2024
Explore the benefits of building a manufacturing process early, how research into LNPs in nucleic acid therapeutics will contribute to the development of future drugs, and more.
-
Recommendations For Successful IND Approval Of RNA-LNP Drugs
8/22/2023
The existing regulatory system is ambiguous for RNA therapeutics. Leverage this Investigational New Drug (IND) guide to help accelerate and strengthen the process IND filing of novel nanomedicines.
-
Improving Medical Device Sustainability
3/29/2023
Product design, production methods, and supply chain can be leveraged to positively impact sustainability through effective planning.
-
How To Get Started With Organ-On-A-Chip Technology
4/18/2024
Explore the advantages of Organ-on-a-Chip technology over 2D cell culture as well as data-driven examples demonstrating the enhanced physiological relevance of Organ-Chips.
-
Accelerating Drug Development For Inflammatory Bowel Disease With Organ-Chips
3/25/2024
Marianne Kanellias unveils how Emulate's Organ-on-a-Chip technology is revolutionizing the field by enabling a more accurate and complex model of IBD pathogenesis.
-
Genome Editing Using mRNA-Lipid Nanoparticles For CAR T Cell Therapy
11/22/2023
Gene delivery platforms must support a diversity of genetic engineering strategies for genomic medicine development. Learn how lipid nanoparticles can accelerate development from discovery to scale-up.
-
Generating A Robust Host Cell Line For A Cell Line Development Platform
11/14/2022
Learn how cell performance within the context of the cell line development workflow was confirmed with the successful isolation of stable, high-producing clones from three model monoclonal antibodies.
-
Formulation Considerations For Pediatric Populations
8/19/2022
By partnering with a CDMO with experience in pediatric formulation, pharmaceutical companies can increase acceptability of their drugs among pediatric patients.
-
Systems Employ New Single-Pass TFF Technology To Simplify Processes And Lower Costs
7/20/2022
Single-pass TFF technology brings practical and economic advances to TFF by simplifying the process and creating new capabilities.